Yangzhenhua 851

MENU

  • HOME

  • ABOUT US

    • Company Profile

    • Inventor

    • Origin of 851

    • Company News

    • Overseas Market

  • PRODUCTS

  • RESEARCH FRONT

  • CONTACT US

  • 中文版

hmbci-201210(3)301–314-PTSD

2021-02-24


 

Previous

FolderZhenHua_E_Tina

hmbci-20118(2)455–469-ManagingImunity

Next

Previous

FolderZhenHua_E_Tina

Next

hmbci-20118(2)455–469-ManagingImunity

Categories

Submit
%{tishi_zhanwei}%

Categories

Researchtheme on anti-aging and others

Researchtheme on cancer

Researchtheme on ALS

Research theme on improvement of immunity

Recent posts

Fermented Soy Beverage Q-CAN Plus Consumption Improves Serum Cholesterol and Cytokines

2026-10-30

Isoflavone Stability Quality Control Assessment of Q-CAN® Plus, a Novel Fermented Soy Beverage (P12-034-19)

2026-10-30

Fermented Soy Drink (Q-CAN® PLUS) Induces Apoptosis and Reduces Viability of Cancer Cells

2026-10-29

Effect of the Fermented Soy Q-CAN® Product on Biomarkers of Inflammation and Oxidation in Adults with Cardiovascular Risk, and Canonical Correlations between the Inflammation Biomarkers and Blood Lipids

2026-10-29

Effects of Fermented Soy on Cognition in Older Adults

2025-09-30

The fermented soy beverage Q-CAN® plus induces beneficial changes in the oral and intestinal microbiome

2025-06-03

Copyright © Fujian Yang Zhenhua 851 Bio-Science Co., Ltd  Powered by www.300.cn

Business Licence   SEO